To explore the functional role of FOXO4 in senescence, its expression was silenced using siRNA in TM3 Leydig cells prior to H2O2-induced senescence
[DOI] [PubMed] 173.Ohsawa Y., Hagiwara H., Nishimatsu S.I., Hirakawa A., Kamimura N., Ohtsubo H., Fukai Y., Murakami T., Koga Y., Goto Y.I., Ohta S., Sunada Y
V., Goldacre, R., Skingsley, A., Conlon, C
Originally approved for Type 2 Diabetes, Tirzepatide is the first and only medication that activates both the GLP-1 and GIP hormone pathways
Notably, reduced m6A levels have been shown to facilitate the degradation of Pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2) mRNA through the YTH domain family protein 2 (YTHDF2) reader, thereby suppressing its expression (198)
The standard protocol starts tirzepatide at 2.5 mg regardless of prior semaglutide dose, then escalates every 4 weeks based on tolerance